fda and tirzepatide compounding Speak up share your perspective with the FDA. : r/tirzepatidecompound May 18, 2026: FDA warns

Cost constraints manifest at multiple levels, including a lack of reimbursement for AOMs, restricted surgical access, inadequate infrastructure, and inequitable distribution of clinical resources

Baseline Characteristics from Evoke and Evoke+: Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimers Disease (P11-9.013)

Hormones released from the gastrointestinal tract upon presentation of nutrients are known collectively as incretins

Both the American Diabetes Association (ADA), in conjunction with the European Association for the Study of Diabetes (EASD), and KDIGO provide clinical practice guidelines for diabetes management in CKD [2, 3]

it is a significant, legally sanctioned market opportunity

This represents an entirely different mechanistic approach - oral insulin delivery - which could reshape the T2D treatment algorithm if approvals and commercialization succeed